Table 2.
Summary of behavioral and biological outcomes by condition
| Male n = 1775 | Female n = 2137 | Overall n = 3912 | ||||
|---|---|---|---|---|---|---|
| Intervention | Control | Intervention | Control | Intervention | Control | |
| Behavioral outcome | N=906 | N=869 | N=1073 | N=1064 | N=1979 | N=1933 |
| Any unprotected sex | ||||||
| Baseline | 103 (11.4) | 101 (11.6) | 25 (2.3) | 26 (2.4) | 128 (6.5) | 127 (6.6) |
| 12-month | 82 (10.8) | 58 (8.4) | 5 (0.5) | 12 (1.3) | 87 (5.0) | 70 (4.3) |
| 24-month | 59 (8.4) | 59 (8.8) | 4 (0.4) | 8 (0.9) | 63 (3.9) | 67 (4.2) |
| Biological outcome | N=905 | N=869 | N=1073 | N=1063 | N=1978 | N=1932 |
| Any (New) STIs | ||||||
| Baseline | 121 (13.4) | 134 (15.4) | 252 (23.5) | 258 (24.3) | 373 (18.9) | 392 (20.3) |
| 12-month | 29 (3.8) | 29 (4.2) | 81 (8.5) | 83 (9.0) | 110 (6.4) | 112 (6.9) |
| 24-month | 27 (3.8) | 22 (3.3) | 52 (5.7)* | 75 (8.3) | 79 (4.9) | 97 (6.2) |
N=Sample size at baseline.
*
Significantly fewer females in the intervention condition experienced any new STIs at 24-month follow-up than those in the control condition (Fisher’s exact test, p=0.043).